Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Inotuzumab Chemical Structure
BCP47871 Inotuzumab 1660159-36-3
Inotuzumab is an antibody-drug conjugate, a type of drug in which an anticancer drug is chemically linked to another molecule that helps target the drug to cancer cells.
Burosumab Chemical Structure
BCP47491 Burosumab 1610833-03-8
Burosumab, a fully human monoclonal antibody to FGF23, is the only approved treatment for X-linked hypophosphatemia (XLH), a rare genetic disorder characterized by renal phosphate wasting and substantial cumulative musculoskeletal morbidity.
Emactuzumab Chemical Structure
BCP47405 Emactuzumab 1448221-67-7
Emactuzumab is a monoclonal antibody against the colony-stimulating factor-1 receptor and targets tumor-associated macrophages (TAMs).
Cudarolimab Chemical Structure
BCP47358 Cudarolimab 2244739-29-3
Cudarolimab is a recombinant fully human anti-OX40 (tumour necrosis factor receptor superfamily member 4) monoclonal antibody.
Perakizumab Chemical Structure
BCP47320 Perakizumab 1331830-76-2
Perakizumab is humanized monoclonal antibody that targets IL17A. It has an immunomodulator activity and is used in the treatment of arthritis.
Remtolumab Chemical Structure
BCP47319 Remtolumab 1791410-27-9
Remtolumab is a dual-variable domain immunoglobulin, targeting tumour necrosis factor (TNF) and interleukin-17 (IL-17).
Orticumab Chemical Structure
BCP47316 Orticumab 1314241-10-5
Orticumab is a fully-human monoclonal antibody against a specific oxidized low-density lipoprotein (LDL) epitope.
MORAb-028 Chemical Structure
BCP47315 MORAb-028 MORAb-028
MORAb-028 is an Anti-Ganglioside GD2 mAb.
Nivatrotamab Chemical Structure
BCP47290 Nivatrotamab 2278244-14-5
Nivatrotamab is a fully humanised bispecific antibody targeting both GD 2 and CD 3 receptors.
Eluvixtamab Chemical Structure
BCP47235 Eluvixtamab 1679391-73-1
Eluvixtamab is a bispecific antibody targeting cell surface markers CD33 and CD3.
123下一页末页共 837 条记录 1 / 84 页 
0086-13720134139